Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency

By afschroeder • August 8, 2025

Nasseri Moghaddam Z, Reinhardt EK, Thurm A, Potter BK, Smith M, Graham C, Tiller BH, Baker SA, Bilder DA, Bogar R, Britz J, Cafferty R, Coller DP, DeGrauw TJ, Hall V, Lipshutz GS, Longo N, Mercimek-Andrews S, Miller JS, Pasquali M, Salomons GS, Schulze A, Wheaton CP, Williams KF, Young SP, Li J, Balog S, Selucky T, Stöckler-Ipsiroglu S, Wallis H. Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency. Orphanet J Rare Dis. 2025 Aug 7;20(1):408. doi: 10.1186/s13023-025-03900-3. PMID: 40775643.

Tags: Core outcome set (COS), Creatine transporter deficiency, Endocrinology, Guanidinoacetate methyltransferase deficiency, Patient focused drug development. Patient-centered research, Publications, rare disease

Healing mechanisms of Galectin-1 in the ischemic heart

Luo NY, Ovuegbe C, Huang J, Thankam FG. Healing mechanisms of Galectin-1 in the ischemic heart. Cell Biochem Biophys. 2026 Apr 11. doi: 10.1007/s12013-026-02069-1. Epub[...]

Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma

Yu R, Gardner L, Salavati A, Bahri S. Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. AACE[...]

Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility

Leung AM, Brent GA, Larson SM, Osborne JR, Flavell RR, Ringel MD, Sosa JA. Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility. Thyroid.[...]